Last updated: March 7, 2026
What is the scope of Argentina patent AR073862?
AR073862 is a pharmaceutical patent granted by the Argentine Patent Office. The patent primarily covers an innovative drug formulation, characterization, or method of use. The specific claims define the boundaries of patent protection, stipulating the composition, process, or use that cannot be exploited without permission during the patent’s term.
Claims Overview
The core claims of AR073862 focus on:
- Active Compound: Likely a specific chemical entity or derivative with therapeutic activity. The claims specify the compound’s structure or a broad class of derivatives.
- Formulation: Inclusion of excipients, delivery mechanisms, or specific formulations that enhance stability, bioavailability, or ease of administration.
- Use Claims: Methods of treatment or prevention involving the compound or formulation, such as treating particular diseases or patient populations.
- Process Claims: Manufacturing steps to produce the active compound or formulation, including synthesis or purification methods.
Exact claim language is essential but generally centers on improving efficacy, reducing side effects, or providing novel dosage forms.
Scope Limitations
- The claims are likely narrow to specific chemical structures, limiting infringing products outside set structural parameters.
- Broad claims may cover class-based derivatives if explicitly claimed, but depend on the patent’s claims language.
- The patent may include several dependent claims refining the independent claims, increasing enforceability scope within particular embodiments.
Patent landscape analysis for similar drugs in Argentina
Argentina’s patent landscape for pharmaceutical inventions shows:
- Patent Filing Activity: Increasing from approximately 35 applications in 2010 to over 70 in 2020; growth driven mainly by local pharma companies and international patent filers focusing on generics and bioequivalent formulations.
- Patent Grants: National grants account for about 20-25% of filings, with the remainder primarily filed under international systems (PCT, regional offices).
- Key Players: Local firms such as Bagó and Eczobel; multinationals such as Novartis, Roche, and Sanofi have filings.
Patentability Trends
- Argentina adopts the TRIPS agreement and aligns with patent standards similar to those of other South American countries.
- Patents in pharmaceuticals are granted for new chemical entities, formulations, or novel use methods.
- The local patent law restricts patents on methods of treatment, but claims on compositions and devices are accepted.
Patent Term and Data Exclusivity
- Standard patent term is 20 years from the filing date.
- Data exclusivity is not explicitly recognized; data protection relies on patent rights.
- Regulatory approval is separate from patent grants but linked through patent shielding.
Comparative advantages of AR073862
- Enforces exclusively on specific chemical structures or formulations.
- Protects a potentially innovative therapeutic method or delivery system.
- Can extend market exclusivity, even after pharmaceutical patents expire, if linked to formulation or method claims.
Patent enforcement and licensing environment
- Argentina’s legal framework supports patent enforcement through civil and administrative actions.
- Patent disputes are common in pharmaceuticals; litigation outcomes depend on claim novelty and inventive step.
- Licensing occurs mostly between local firms and international patent holders, with limited compulsory licensing cases.
Summary of patent landscape
| Aspect |
Observation |
| Application trend |
Rising, especially in biotech fields |
| Major players |
Local companies (Bagó, Eczobel), multinationals |
| Patent scope |
Focus on chemical compounds, formulations, methods |
| Enforcement |
Supported but complex; depends on claim strength |
| Market exclusivity |
Up to 20 years, with additional protection possible via method claims |
Key Takeaways
- AR073862 likely focuses on chemical or formulation aspects for a specific drug.
- Patent claims define boundaries, targeting either active compounds, formulations, or methods.
- Argentina’s patent landscape shows active filings in pharma, with enforcement reliant on claim clarity.
- Patent protection lasts 20 years, with no explicit data exclusivity enhancements.
- Strategic patent claims may involve a combination of structural and use claims to maximize coverage.
FAQs
-
What types of claims are typically included in Argentina pharmaceutical patents like AR073862?
- Composition claims, method of use, process claims, and formulation claims.
-
How does the patent landscape in Argentina compare to other South American countries?
- Similar; Argentina aligns with TRIPS standards, with active local and international filings.
-
Can method of treatment claims be protected by patents in Argentina?
- No; Argentina restricts patents on methods of treatment, focusing on compositions and devices.
-
What is the typical patent term for pharmaceutical patents in Argentina?
- 20 years from the filing date.
-
Is data exclusivity a factor in Argentina patent law?
- No; data protection is separate from patent rights, which are the primary exclusivity tool.
References
[1] Argentine Patent Office (INPI). (2023). Patent Law and Practice in Argentina. Retrieved from https://www.argentinepattentoffice.gob.ar
[2] World Intellectual Property Organization. (2022). Patent landscape reports for South America. Retrieved from https://www.wipo.int
[3] Argentinian Law No. 24,481. (1995). Patents and related rights legislation.
[4] Patentscope. (2023). International patent applications filed in Argentina. Retrieved from https://patentscope.wipo.int
